Related references
Note: Only part of the references are listed.Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
Silvia Nuzzo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells
Mahsa Ramezanpour et al.
MOLECULAR BIOLOGY REPORTS (2019)
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells
Alessandra Affinito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Carlo Rinaldi et al.
NATURE REVIEWS NEUROLOGY (2018)
Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy
Ka Ming Pang et al.
NUCLEIC ACIDS RESEARCH (2018)
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
Xiulong Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
In vitro inhibition of porcine reproductive and respiratory syndrome virus replication by short antisense oligonucleotides with locked nucleic acid modification
Lingyun Zhu et al.
BMC VETERINARY RESEARCH (2018)
Liposomal Drug Delivery Systems and Anticancer Drugs
Temidayo O. B. Olusanya et al.
MOLECULES (2018)
Application of 2′-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides
Yoshiaki Masaki et al.
NUCLEIC ACID THERAPEUTICS (2018)
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Carla Lucia Esposito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2(+) Breast Cancer
Xiaolin Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells
Valentina Russo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
Jianxu Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
FDA-Approved Oligonucleotide Therapies in 2017
Cy A. Stein et al.
MOLECULAR THERAPY (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
Pharmacokinetic Properties of DNA Aptamers with Base Modifications
Shashi Gupta et al.
NUCLEIC ACID THERAPEUTICS (2017)
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
Chiranjib Chakraborty et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Sven Kruspe et al.
BIOMEDICINES (2017)
Challenges and opportunities for siRNA-based cancer treatment
Tao Wang et al.
CANCER LETTERS (2017)
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
Nancy J. Ganson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
Carla L. Esposito et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
DRUG DELIVERY Nanoparticles improve profile of molecularly targeted cancer drug
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2016)
Splice-switching antisense oligonucleotides as therapeutic drugs
Mallory A. Havens et al.
NUCLEIC ACIDS RESEARCH (2016)
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
NUCLEIC ACIDS RESEARCH (2016)
Building a chimera of aptamer-antisense oligonucleotide for silencing galectin-1 gene
Shanni Hong et al.
RSC Advances (2016)
Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
Hong Yan Liu et al.
SCIENTIFIC REPORTS (2016)
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
Margherita Iaboni et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Modern affinity reagents: Recombinant antibodies and aptamers
Katherine Groff et al.
BIOTECHNOLOGY ADVANCES (2015)
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Ulrich Laechelt et al.
CHEMICAL REVIEWS (2015)
Oligonucleotide Therapies: The Past and the Present
Karin E. Lundin et al.
HUMAN GENE THERAPY (2015)
A Universal Aptamer Chimera for the Delivery of Functional microRNA-126
Jan-H. Rohde et al.
NUCLEIC ACID THERAPEUTICS (2015)
Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist's Perspective
Kendall S. Frazier
TOXICOLOGIC PATHOLOGY (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Yi Shu et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras
Wei-Yun Lai et al.
BIOMATERIALS (2014)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Genomic Portrait of Resectable Hepatocellular Carcinomas: Implications of RB1 and FGF19 Aberrations for Patient Stratification
Sung-Min Ahn et al.
HEPATOLOGY (2014)
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Carla L. Esposito et al.
MOLECULAR THERAPY (2014)
Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
Justin P. Dassie et al.
MOLECULAR THERAPY (2014)
Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy
Jiehua Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Gene Therapy Delivery Systems for Enhancing Viral and Nonviral Vectors for Cardiac Diseases: Current Concepts and Future Applications
Michael G. Katz et al.
HUMAN GENE THERAPY (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
S. Catuogno et al.
ONCOGENE (2013)
Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors
Ashley A. Manzoor et al.
CANCER RESEARCH (2012)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Cell-penetrating Peptides as Versatile Vehicles for Oligonucleotide Delivery
Helerin Margus et al.
MOLECULAR THERAPY (2012)
Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice
Jun Yang et al.
NANOMEDICINE (2012)
Aptamer-Mediated Delivery of Splice-Switching Oligonucleotides to the Nuclei of Cancer Cells
Jonathan W. Kotula et al.
NUCLEIC ACID THERAPEUTICS (2012)
Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
Xin Wu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex
Eunjung Kim et al.
BIOMATERIALS (2010)
miR-212 Increases Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Sensitivity in Non-Small Cell Lung Cancer by Targeting the Antiapoptotic Protein PED
Mariarosaria Incoronato et al.
CANCER RESEARCH (2010)
siRNA Conjugate Delivery Systems
Ji Hoon Jeong et al.
BIOCONJUGATE CHEMISTRY (2009)
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Sridharan Soundararajan et al.
MOLECULAR PHARMACOLOGY (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Differential SELEX in Human Glioma Cell Lines
Laura Cerchia et al.
PLOS ONE (2009)
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts
Jennifer H. E. Baker et al.
CLINICAL CANCER RESEARCH (2008)
Cell-Specific Induction of Apoptosis by Rationally Designed Bivalent Aptamer-siRNA Transcripts Silencing Eukaryotic Elongation Factor 2
Ulrich Wullner et al.
CURRENT CANCER DRUG TARGETS (2008)
PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer
Ciro Zanca et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
miR-122, a paradigm for the role of microRNAs in the liver
Muriel Girard et al.
JOURNAL OF HEPATOLOGY (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to Anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer
K. Eszter Borbas et al.
BIOCONJUGATE CHEMISTRY (2007)
Argonaute proteins: Mediators of RNA silencing
Lasse Peters et al.
MOLECULAR CELL (2007)
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
Huban Kutay et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Aptamer mediated siRNA delivery
Ted C. Chu et al.
NUCLEIC ACIDS RESEARCH (2006)
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes
C Matranga et al.
CELL (2005)
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs
HJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Identification of mammalian microRNA host genes and transcription units
A Rodriguez et al.
GENOME RESEARCH (2004)
Expression profiling reveals off-target gene regulation by RNAi
AL Jackson et al.
NATURE BIOTECHNOLOGY (2003)
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
PJ Paddison et al.
GENES & DEVELOPMENT (2002)
Protamine-fragment peptides fused to an SV40 nuclear localization signal deliver oligonucleotides that produce antisense effects in prostate and bladder carcinoma cells
L Benimetskaya et al.
BIOCONJUGATE CHEMISTRY (2002)
Share Paper
